Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$415M |
| 2 |
Eli Lilly
LLY
|
+$402M |
| 3 |
Goldman Sachs
GS
|
+$384M |
| 4 |
McDonald's
MCD
|
+$379M |
| 5 |
Tesla
TSLA
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.98B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 3 |
AT&T
T
|
+$460M |
| 4 |
Synchrony
SYF
|
+$398M |
| 5 |
Honeywell
HON
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.53% |
| 2 | Financials | 4.78% |
| 3 | Healthcare | 3.89% |
| 4 | Industrials | 3.6% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
iShares 20+ Year Treasury Bond ETF
TLT
$41.4B
| $9.49M | ﹤0.01% |
75,085
-124,240
| -62% | -$15.1M |
|
|
BPY
2027
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $9.49M | ﹤0.01% |
461,234
+285,449
| +162% | +$5.4M |
|
2028
CALL
Neurocrine Biosciences
NBIX
$16.7B
| $9.49M | ﹤0.01% |
107,700
-129,100
| -55% | -$10.8M |
|
|
WWE
2029
CALL
DELISTED
World Wrestling Entertainment
WWE
| $9.48M | ﹤0.01% |
109,300
+200
| +0.2% | +$16.8K |
|
|
AUD
2030
DELISTED
Audacy, Inc.
AUD
| $9.45M | ﹤0.01% |
1,799,552
+1,316,267
| +272% | +$8.71M |
|
|
VAR
2031
CALL
DELISTED
Varian Medical Systems, Inc.
VAR
| $9.44M | ﹤0.01% |
66,600
+1,300
| +2% | +$171K |
|
2032
PUT
AerCap
AER
$24.2B
| $9.44M | ﹤0.01% |
202,800
+100,200
| +98% | +$4.52M |
|
2033
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.6B
| $9.43M | ﹤0.01% |
+259,181
| New | +$9.08M |
|
|
CXP
2034
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $9.43M | ﹤0.01% |
418,766
+357,881
| +588% | +$7.74M |
|
|
TIVO
2035
DELISTED
Tivo Inc
TIVO
| $9.43M | ﹤0.01% |
1,011,331
-39,718
| -4% | -$411K |
|
|
GCP
2036
DELISTED
GCP Applied Technologies Inc.
GCP
| $9.41M | ﹤0.01% |
317,841
+210,927
| +197% | +$5.67M |
|
2037
State Street SPDR S&P Metals & Mining ETF
XME
$3.94B
| $9.39M | ﹤0.01% |
316,398
-9,908
| -3% | -$294K |
|
2038
Ameren
AEE
$30.3B
| $9.39M | ﹤0.01% |
+127,611
| New | +$8.89M |
|
|
PDLI
2039
DELISTED
PDL BioPharma, Inc.
PDLI
| $9.32M | ﹤0.01% |
2,506,735
-1,734,895
| -41% | -$5.86M |
|
2040
PUT
Harley-Davidson
HOG
$2.66B
| $9.31M | ﹤0.01% |
261,200
-74,500
| -22% | -$2.71M |
|
2041
PUT
KLA
KLAC
$239B
| $9.31M | ﹤0.01% |
780,000
-55,000
| -7% | -$592K |
|
2042
CALL
SolarEdge
SEDG
$2.74B
| $9.31M | ﹤0.01% |
247,200
+61,200
| +33% | +$2.44M |
|
2043
CALL
Direxion Daily Gold Miners Index Bear 2X ETF
DUST
$67.1M
| $9.31M | ﹤0.01% |
206
+97
| +89% | +$4.84M |
|
2044
PUT
VF Corp
VFC
$5.87B
| $9.27M | ﹤0.01% |
113,315
+37,807
| +50% | +$2.95M |
|
2045
PUT
Abercrombie & Fitch
ANF
$4.84B
| $9.25M | ﹤0.01% |
337,500
+32,300
| +11% | +$725K |
|
|
WAGE
2046
DELISTED
WageWorks, Inc.
WAGE
| $9.24M | ﹤0.01% |
244,668
+26,050
| +12% | +$850K |
|
2047
CALL
BioMarin Pharmaceuticals
BMRN
$11.6B
| $9.24M | ﹤0.01% |
104,000
+24,300
| +30% | +$2.25M |
|
2048
PUT
Canadian Pacific Kansas City
CP
$79.7B
| $9.23M | ﹤0.01% |
224,000
-26,500
| -11% | -$1.06M |
|
2049
Centene
CNC
$31.5B
| $9.21M | ﹤0.01% |
173,434
-54,146
| -24% | -$3.29M |
|
|
CBIO
2050
Crescent Biopharma
CBIO
$552M
| $9.2M | ﹤0.01% |
7,387
-580
| -7% | -$664K |
|
Similar funds
Citadel Advisors's Q1 2019 Portfolio in Review
As of Q1 2019, Citadel Advisors held 10,449 positions worth $201B, up 10% from $183B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citadel Advisors withdrew a net $12.7B in Q1 2019, closing 1,252 positions and reducing 3,810 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $223M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.5% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Citadel Advisors opened a new position in Elanco Animal Health worth $251M.
- Citadel Advisors's largest Q1 2019 buy was Elanco Animal Health: 7,832,197 shares worth $251M.
- Citadel Advisors added most to Walt Disney in Q1 2019, an estimated $415M increase.
- Citadel Advisors's biggest Q1 2019 reduction was Amazon, cutting an estimated $1.98B.
- Citadel Advisors fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $223M.
- Citadel Advisors's ten largest holdings make up 24% of its $201B portfolio in Q1 2019.
- Citadel Advisors opened 1,430 new positions and closed 1,252 in Q1 2019.
- Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $201B.
Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.